If your child has been told their nearsightedness is getting worse every year, you're not alone. Childhood myopia (nearsightedness) is becoming more common, and unchecked progression doesn't just mean stronger glasses. High myopia is a risk factor for serious lifelong eye conditions including retinal detachment, glaucoma, and macular degeneration. The good news: there are now FDA-approved treatments that have been proven to slow progression. Here's what parents in Chester County and the Main Line need to know.
Myopia happens when the eyeball grows slightly too long, causing distant objects to appear blurry. In children, the eye is still growing, and once myopia starts, it tends to progress year by year through the teenage years.
The concern isn't just thicker glasses. Children whose myopia ends up at -6.00 or higher (high myopia) face significantly elevated lifetime risk of:
This is why myopia control is now considered a medical priority, not just an optical convenience.
MiSight 1 day soft contact lenses use a unique optical design called ActivControl technology. The lens has two zones: a central zone that corrects distance vision and a peripheral zone that creates a specific kind of blur on the retina. This peripheral blur signals the eye to slow its growth.
It sounds counterintuitive that blurring part of the vision helps the eye, but the effect has been well-documented in published studies. The pivotal three-year clinical trial showed that children using MiSight had 59% less myopia progression than children wearing standard contact lenses. The seven-year extension study showed the benefit continued throughout childhood.
MiSight is FDA-approved for children ages 8-12 at the start of treatment, with myopia between -0.75 and -4.00 diopters and minimal astigmatism. The earlier we start, the more cumulative benefit your child gets over their growing years.
Most kids in this age range can successfully wear and care for daily disposable contact lenses. The lenses are inserted in the morning and thrown away at night, so there's no cleaning routine.
For children outside the MiSight age range, who can't wear contacts, or whose myopia is progressing despite MiSight, we sometimes prescribe low-dose atropine eye drops. This is a once-nightly drop that has also been shown to slow myopia progression. We tailor the strategy to each child.
The first visit includes a comprehensive eye exam, axial length measurement (which tracks the actual eye growth), and a thorough discussion with parents about lifestyle factors that contribute to myopia (screen time, outdoor time, reading habits). We then build a treatment plan together.
Children in the program return every six months for monitoring and lens supply. Most parents find these visits reassuring; you can actually see whether progression is slowing.
Most medical insurance plans do not cover MiSight or atropine drops because they're considered elective myopia control rather than treatment of vision. We have transparent self-pay rates and provide a written estimate at the consultation. Some HSA and FSA accounts will cover the program.
The best time to start myopia control is when myopia is first diagnosed and progressing, not after years of progression. If your child's prescription has changed in the last year, a myopia management consultation is worth scheduling.
Call 610-429-3004 or request an appointment. Learn more about our myopia management program or pediatric eye care.
Have questions about your eye care? Our team at Mudgil Eye Associates would love to help.
Call 610-429-3004 or request your appointment online.
Learn more about our services: Cataract Surgery, Glaucoma, Pediatric Eye Care, Dropless Cataract Surgery, Premium IOLs.